Race Oncology Ltd has released a press release.
Race Completes Over-Subscribed $2.5 Million Placement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Racura Oncology
- Race Joint Venture with TargImmune
- Race Announces NCI Collaboration
- Bisantrene License Agreement for Korea
- Pre-IND Meeting Confirms 505(b)(2) Pathway for Bisantrene
- Race Oncology Update & Investor Presentation
Later from Racura Oncology
- Peer-Reviewed The Rediscovery of Bisantrene Published
- Issue of Options
- Appendix 4E & Annual Financial Statements
- Race Oncology Produces First Batch of Bisantrene
- Race Receives $170k R&D Tax Incentive Refund
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology